middle.news
How Is ALS Driving 16% Revenue Growth and Accelerating Nuvisan Integration?
8:25am on Tuesday 27th of May, 2025 AEST
•
Industrial Services
Read Story
How Is ALS Driving 16% Revenue Growth and Accelerating Nuvisan Integration?
8:25am on Tuesday 27th of May, 2025 AEST
Key Points
16% revenue growth to $3 billion with 4.7% increase in underlying EBIT
Nuvisan acquisition integration ahead of plan, delivering early cost savings
Strong organic growth in Life Sciences and Industrial Materials segments
$230 million capital investment to expand four major laboratories by FY30
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Als (ASX:ALQ)
OPEN ARTICLE